[An update of the recommendations of the Spanish Neonatology Society for the use of palivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants]

MeSH terms

• Antiviral Agents / therapeutic use*
• Drug Administration Schedule
• Humans
• Infant, Newborn
• Infant, Premature
• Infant, Premature, Diseases / prevention & control*
• Neonatology
• Palivizumab / therapeutic use*
• Practice Guidelines as Topic*
• Respiratory Syncytial Virus Infections / prevention & control*
• Risk
• Societies, Medical
• Spain